Kalaris Therapeutics, Inc. Q3 GAAP EPS of -$0.46 beats by $0.05
· Seeking Alpha · 市场快讯 · 同事件 2 篇报道
Kalaris Therapeutics, Inc. Q3 GAAP EPS of -$0.46 beats by $0.05. As of September 30, 2026, the company had cash, cash equivalents and marketable securities of $82.9M.
查看报道与原始来源 →